Olympus Co. (OTCMKTS:OLYMY) Short Interest Update

Olympus Co. (OTCMKTS:OLYMY) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 43,336 shares, a growth of 333,253.8% from the June 30th total of 13 shares. Based on an average trading volume of 117,586 shares, the short-interest ratio is currently 0.4 days.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group lowered Olympus from a “buy” rating to a “neutral” rating in a report on Monday, June 15th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.

Olympus Stock Performance

OTCMKTS:OLYMY opened at $10.59 on Friday. Olympus has a fifty-two week low of $8.08 and a fifty-two week high of $13.73. The company has a fifty day moving average of $10.89 and a two-hundred day moving average of $10.62.

Olympus Company Profile

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.